Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03168425 · ClinicalTrials.gov registry record · NA

Opioid Prescribing After Cesarean Delivery

A NA study of Surgery and Opioid Use, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
NA
Development phase
190
Enrollment target
1
Study location

NCT03168425 is a NA study of Surgery and Opioid Use that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 190 participants, below the 52,850-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03168425, a NA study of Surgery and Opioid Use, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
NA
Development phase
190 participants
Enrollment target
1
Study location

Study Summary

The number of opioid overdose deaths in the United States has quadrupled in 15 years, a dramatic manifestation of the current opioid abuse epidemic. This rise parallels a sharp increase in the amount of legal prescription opioids dispensed. The abundance of prescription opioids available is a primary pathway for opioid abuse and diversion. Adjusting post- cesarean delivery opioid prescribing practices to better match actual patient need has the potential to reduce unused opioids available for diversion, nonmedical use, and development of chronic dependence, as well as reduce wasted resources.

Conditions Studied

Surgery Opioid Use

Interventions

  • OTHER Control
  • OTHER Tailored prescription

Study Locations (1)

Tennessee

  • Sarah Osmundson - Nashville

Trial Details

FieldValue
Enrollment Target 190 participants
Start Date 2017-06-14
Est. Completion 2017-09-21
Phase NA

Sponsor

Vanderbilt University Medical Center

677 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03168425

The ClinicalTrials.gov registry entry for NCT03168425 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 52,850-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Surgery appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT03168425 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT03168425 about?

NCT03168425 is a clinical study titled "Opioid Prescribing After Cesarean Delivery". The number of opioid overdose deaths in the United States has quadrupled in 15 years, a dramatic manifestation of the current opioid abuse epidemic. This rise parallels a sharp increase in the amount of legal prescription opioids dispensed. The abundance of prescription opioids available is a primar...

What is the current status of trial NCT03168425?

This trial is currently completed. It is a NA study. The enrollment target is 190 participants. The study started on 2017-06-14. Estimated completion is 2017-09-21.

What conditions does trial NCT03168425 study?

This clinical trial studies the following conditions: Surgery, Opioid Use.

What interventions are being tested in trial NCT03168425?

The interventions under investigation include: Control (OTHER), Tailored prescription (OTHER).

Who is sponsoring clinical trial NCT03168425?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03168425 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Surgery

All registered trials for this condition

Opioid Use

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.